查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2030005

蛋白質檢測市場 - 全球產業規模、佔有率、趨勢、機會、預測：按類型、產品、技術、應用、最終用戶、地區和競爭格局分類，2021-2031年

Protein Assays Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type, By Product, By Technology, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球蛋白質檢測市場預計將從 2025 年的 31.1 億美元成長到 2031 年的 47.3 億美元，複合年成長率為 7.24%。

這些關鍵的生化技術廣泛應用於基礎研究、診斷檢測和藥物研發，用於檢測、定量和表徵生物樣本中的蛋白質。市場成長的主要驅動力是人們對蛋白質體學的日益關注、生物製藥和生物類似藥研發管線的擴展以及個人化醫療的廣泛發展。世界智慧財產權組織（WIPO）發布的《2024年全球創新指數》也印證了這一趨勢，該指數顯示，2023年全球企業研發支出達到約1.2兆美元，其中製藥業的研發投資年增10%。

市場概覽
預測期 2027-2031
市場規模：2025年 31.1億美元
市場規模：2031年 47.3億美元
複合年成長率：2026-2031年 7.24%
成長最快的細分市場 染料結合試驗
最大的市場 北美洲

儘管成長要素強勁，但市場仍面臨許多可能阻礙其發展的重大障礙。對先進設備的巨額前期投資，以及對執行複雜流程和分析複雜數據的訓練有素人員的需求，仍然是市場大規模擴張的主要障礙。

市場促進因素

製藥和生物技術領域研發投入的增加是全球蛋白質檢測市場的主要驅動力，加速了新型藥物標靶的發現和檢驗。這些檢測方法貫穿藥物研發的各個階段，從早期發現到臨床試驗，都發揮著至關重要的作用，能夠評估蛋白質-蛋白質相互作用、識別生物標記並評估治療效果。例如，強生公司2025年第四季財報（2026年1月發布）顯示，全年研發支出將達到147億美元，這反映了該公司對創新的堅定承諾，也推動了對先進蛋白質分析工具的需求。這種持續的資金支持確保了依賴全面蛋白質評估的、前景廣闊的治療方法的穩定供應。

生物製藥行業的持續成長也是市場的主要驅動力，因為該行業高度依賴精準的蛋白質檢測技術進行產品開發、品質保證以及遵守嚴格的法規。生產生物製藥和生物相似藥等蛋白質療法需要對生產的每個階段進行持續監控，以確保其安全性、有效性和純度。根據英國製藥製造商協會2025年5月20日發布的報告，BioNTech承諾在未來十年內投資高達10億英鎊，以擴大其在英國的業務，這表明該公司致力於業務擴張，而這將自然而然地促進蛋白質檢測技術的應用。此外，生物技術創新組織（BIO）2025年7月發布的報告強調，生技新創公司在當年第一季成功資金籌措，凸顯了生命科學領域對蛋白質分析技術的資金投入正在不斷成長。

市場挑戰

購置尖端設備所需的大量資金直接阻礙了全球蛋白質檢測市場的擴張。購買自動化液體處理系統和質譜儀等先進平台的高昂前期成本，對小規模研究機構和新興生物技術公司構成了巨大的財務障礙。這種經濟壓力限制了用於全面蛋白質評估的新一代工具的普及。 2023 年《實驗室經理》雜誌的一項調查凸顯了這種謹慎的支出環境，調查顯示，僅有 35% 的受訪者預計其 2024 年二手購置新舊實驗室設備的預算將會增加。這種財務限制制約了實驗室升級技術和擴展檢測能力。

除了這些財務方面的挑戰之外，市場對能夠操作複雜儀器並解讀精細分析資料的訓練有素的專業人員的需求也非常旺盛。精通高級蛋白質檢測和生物資訊學的熟練人才短缺，導致長期培訓計畫和高薪要求不斷推高日常營運成本。最終，巨額的前期投入和人才短缺的雙重負擔，透過提高整體成本並限制人們獲得這些關鍵科學資源，阻礙了市場的整體成長。

市場趨勢

多重高通量檢測系統的發展是改變全球蛋白質檢測市場的決定性趨勢，使研究人員能夠同時評估大量樣本中的多種蛋白質標靶。這項技術突破將顯著提高蛋白質表徵的速度，這對於大規模蛋白質體學研究和藥物發現至關重要。使用更少的試劑和更小的樣本量處理大規模資料集，可以降低每個樣本的成本並加快研究週期。例如，根據《蛋白質體學產業新聞》2025年2月報道，英國生物銀行製藥蛋白質體學計畫計畫使用賽默飛世爾科技的Orbitrap Ascend Ultra等系統，對60萬個樣本中的5,400多種蛋白質進行檢測。這種對多重檢測的重視與臨床和研究領域對快速、全面的蛋白質分析日益成長的需求完美契合。

另一項創新趨勢是將機器學習 (ML) 和人工智慧 (AI) 引入檢測評估，從而將傳統的資料處理方式轉變為先進的預測建模。透過識別蛋白質檢測產生的大量資料集中的複雜模式，AI 和 ML 技術能夠提高準確性、消除分析瓶頸，並揭示先前被忽視的藥物標靶和生物標記。這種轉變使得更精確的定量分析、自動化品質檢查以及對細胞網路更深入的洞察成為可能。 Benzinga 在 2026 年 4 月報道稱，PRECISE-SG100K 研究利用了包括 Seer 公司 Proteograph 產品套件在內的多種技術，透過繪製 10,000 名受試者的血漿蛋白質組圖譜，最終加速了生物標記的檢測，這印證了上述趨勢。這些智慧分析儀器對於最大限度地效用複雜的檢測數據以及推動生物製藥和標靶治療的進步至關重要。

目錄

第1章 產品概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球蛋白質檢測市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按類型（染料結合法、試紙法、銅離子法、其他）
    • 依產品分類（試劑、試劑盒、儀器、配件）
    • 依技術（比色法蛋白質測定、螢光法蛋白質測定、吸光度法蛋白質測定）
    • 按應用領域（藥物發現/開發、疾病診斷、其他）
    • 依最終用戶（製藥和生物技術公司、臨床檢查室、醫院、學術研究機構等）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美蛋白質檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲蛋白質檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區蛋白質檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲蛋白質檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲蛋白質檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球蛋白質檢測市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Becton Dickinson and Co
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories Inc
  • Merck KGaA
  • Abcam PLC
  • PerkinElmer Inc.
  • QIAGEN NV
  • Lonza Group AG
  • Bio-Techne Corp
  • Illumina Inc

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 7415

The Global Protein Assays Market is anticipated to expand from USD 3.11 billion in 2025 to USD 4.73 billion by 2031, reflecting a compound annual growth rate (CAGR) of 7.24%. These crucial biochemical techniques are widely used to detect, quantify, and characterize proteins in biological samples across basic research, diagnostic testing, and drug development. Market growth is primarily fueled by an intensified emphasis on proteomics, a growing pipeline of biologics and biosimilars, and the broader shift toward personalized medicine. Supporting this trajectory, the World Intellectual Property Organization's 2024 Global Innovation Index noted that global corporate research and development spending hit about $1.2 trillion in 2023, accompanied by a 10% year-over-year increase in pharmaceutical R&D investments.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 3.11 Billion
Market Size 2031USD 4.73 Billion
CAGR 2026-20317.24%
Fastest Growing SegmentDye Binding Assays
Largest MarketNorth America

Even with these strong growth catalysts, the market faces notable hurdles that could slow its advancement. The need for significant upfront financial investments in sophisticated equipment, coupled with the necessity for highly trained personnel to execute complex procedures and analyze difficult data, remains a prominent barrier to widespread expansion.

Market Driver

Rising research and development investments in the pharmaceutical and biotechnology sectors are major catalysts for the Global Protein Assays Market, accelerating the discovery and validation of novel drug targets. These assays serve as vital instruments across all phases of drug development-from initial discovery to clinical testing-enabling the assessment of protein interactions, biomarker identification, and therapeutic efficacy. For example, Johnson & Johnson's Q4 2025 Earnings Report (January 2026) highlighted a full-year R&D spend of $14.7 billion, reflecting a deep commitment to innovation that fuels the need for advanced protein analysis tools. Such sustained financial backing guarantees a steady flow of prospective therapies that all depend on comprehensive protein evaluation.

The continued growth of the biopharmaceutical sector acts as another primary market driver, as it heavily relies on accurate protein measurement for product creation, quality assurance, and strict regulatory adherence. Manufacturing protein-based treatments like biologics and biosimilars requires constant oversight to guarantee safety, strength, and purity at every production phase. As reported by the Association of the British Pharmaceutical Industry on May 20, 2025, BioNTech pledged up to £1 billion over a decade to grow its UK footprint, illustrating scaling initiatives that naturally boost protein assay usage. Additionally, a July 2025 Biotechnology Innovation Organization report showed biotech startups secured $2.6 billion during the first quarter of the year, emphasizing the escalating financial support for protein analysis technologies throughout the life sciences field.

Market Challenge

The steep capital requirements for state-of-the-art equipment present a direct obstacle to the expansion of the Global Protein Assays Market. Purchasing advanced platforms, including automated liquid handlers and mass spectrometers, involves hefty initial expenses that form major financial roadblocks for smaller research facilities and newer biotech firms. This economic pressure restricts the integration of next-generation tools necessary for thorough protein evaluation. Highlighting this cautious spending environment, a 2023 survey by Lab Manager revealed that a mere 35 percent of respondents expected their budgets for both new and used laboratory equipment to grow in 2024. Such constrained funding limits the ability of labs to upgrade their technology and broaden their assay capacities.

Adding to these financial hurdles is the intense need for highly trained experts who can run these complex machines and decipher intricate analytical data. A shortage of skilled personnel proficient in high-level protein assays and bioinformatics drives up daily operating expenses, driven by the need for lengthy training programs and premium salaries. Ultimately, the combined weight of massive upfront costs and the struggle to secure specialized talent curtails broader market growth by raising the overall expense and restricting access to these indispensable scientific resources.

Market Trends

The creation of multiplexed and high-throughput assay systems is a defining trend transforming the Global Protein Assays Market, allowing researchers to evaluate multiple protein targets across numerous samples simultaneously. This leap in technology vastly improves the speed of protein characterization, which is essential for massive proteomics initiatives and pharmaceutical discovery. Processing larger datasets while using fewer reagents and smaller sample volumes helps decrease individual sample costs and speeds up research cycles. For instance, Proteomics Industry News reported in February 2025 that the UK Biobank Pharma Proteomics Project intends to measure over 5,400 proteins in 600,000 samples utilizing systems like Thermo Fisher Scientific's Orbitrap Ascend Ultra. This emphasis on multiplexing perfectly aligns with the surging need for fast, thorough protein profiling in both clinical and research settings.

Another revolutionary trend is the incorporation of machine learning and artificial intelligence into assay evaluation, which elevates traditional data handling into advanced predictive modeling. By recognizing intricate patterns within the massive datasets produced by protein assays, AI and ML technologies enhance precision, clear analytical logjams, and uncover unseen drug targets and biomarkers. This shift allows for more accurate quantification, automated quality checks, and enriched insights into cellular networks. Highlighting this trend, Benzinga reported in April 2026 that the PRECISE-SG100K study is leveraging Seer Inc.'s Proteograph Product Suite alongside other technologies to map the plasma proteomes of 10,000 individuals, ultimately accelerating biomarker detection. These smart analytical instruments are critical for maximizing the utility of complex assay data, driving progress in biopharmaceuticals and targeted therapies.

Key Market Players

  • Becton Dickinson and Co
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories Inc
  • Merck KGaA
  • Abcam PLC
  • PerkinElmer Inc.
  • QIAGEN NV
  • Lonza Group AG
  • Bio-Techne Corp
  • Illumina Inc

Report Scope

In this report, the Global Protein Assays Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Protein Assays Market , By Type

  • Dye Binding Assays
  • Test Strip-Based Assays
  • Copper-Ion-Based Assays
  • Others

Protein Assays Market , By Product

  • Reagents
  • Kits
  • Instruments
  • Accessories

Protein Assays Market , By Technology

  • Colorimetric Protein Assays
  • Fluorescence-Based Protein Assays
  • Absorbance-Based Protein Assays

Protein Assays Market , By Application

  • Drug Discovery and Development
  • Disease Diagnosis
  • Others

Protein Assays Market , By End User

  • Pharmaceutical and Biotechnology Companies
  • Clinical Laboratories
  • Hospitals
  • Academic Research Institutes
  • Others

Protein Assays Market , By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Protein Assays Market .

Available Customizations:

Global Protein Assays Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Protein Assays Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Dye Binding Assays, Test Strip-Based Assays, Copper-Ion-Based Assays, Others)
    • 5.2.2. By Product (Reagents, Kits, Instruments, Accessories)
    • 5.2.3. By Technology (Colorimetric Protein Assays, Fluorescence-Based Protein Assays, Absorbance-Based Protein Assays)
    • 5.2.4. By Application (Drug Discovery and Development, Disease Diagnosis, Others)
    • 5.2.5. By End User (Pharmaceutical and Biotechnology Companies, Clinical Laboratories, Hospitals, Academic Research Institutes, Others)
    • 5.2.6. By Region
    • 5.2.7. By Company (2025)
  • 5.3. Market Map

6. North America Protein Assays Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Product
    • 6.2.3. By Technology
    • 6.2.4. By Application
    • 6.2.5. By End User
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Protein Assays Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Product
        • 6.3.1.2.3. By Technology
        • 6.3.1.2.4. By Application
        • 6.3.1.2.5. By End User
    • 6.3.2. Canada Protein Assays Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Product
        • 6.3.2.2.3. By Technology
        • 6.3.2.2.4. By Application
        • 6.3.2.2.5. By End User
    • 6.3.3. Mexico Protein Assays Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Product
        • 6.3.3.2.3. By Technology
        • 6.3.3.2.4. By Application
        • 6.3.3.2.5. By End User

7. Europe Protein Assays Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Product
    • 7.2.3. By Technology
    • 7.2.4. By Application
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Protein Assays Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By Technology
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End User
    • 7.3.2. France Protein Assays Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By Technology
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End User
    • 7.3.3. United Kingdom Protein Assays Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By Technology
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End User
    • 7.3.4. Italy Protein Assays Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Product
        • 7.3.4.2.3. By Technology
        • 7.3.4.2.4. By Application
        • 7.3.4.2.5. By End User
    • 7.3.5. Spain Protein Assays Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Product
        • 7.3.5.2.3. By Technology
        • 7.3.5.2.4. By Application
        • 7.3.5.2.5. By End User

8. Asia Pacific Protein Assays Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Product
    • 8.2.3. By Technology
    • 8.2.4. By Application
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Protein Assays Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By Technology
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
    • 8.3.2. India Protein Assays Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By Technology
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
    • 8.3.3. Japan Protein Assays Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By Technology
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
    • 8.3.4. South Korea Protein Assays Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Product
        • 8.3.4.2.3. By Technology
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
    • 8.3.5. Australia Protein Assays Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Product
        • 8.3.5.2.3. By Technology
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User

9. Middle East & Africa Protein Assays Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Product
    • 9.2.3. By Technology
    • 9.2.4. By Application
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Protein Assays Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By Technology
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
    • 9.3.2. UAE Protein Assays Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By Technology
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
    • 9.3.3. South Africa Protein Assays Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By Technology
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User

10. South America Protein Assays Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Product
    • 10.2.3. By Technology
    • 10.2.4. By Application
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Protein Assays Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By Technology
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
    • 10.3.2. Colombia Protein Assays Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By Technology
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User
    • 10.3.3. Argentina Protein Assays Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By Technology
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Protein Assays Market : SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Becton Dickinson and Co
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Thermo Fisher Scientific Inc.
  • 15.3. Bio-Rad Laboratories Inc
  • 15.4. Merck KGaA
  • 15.5. Abcam PLC
  • 15.6. PerkinElmer Inc.
  • 15.7. QIAGEN NV
  • 15.8. Lonza Group AG
  • 15.9. Bio-Techne Corp
  • 15.10. Illumina Inc

16. Strategic Recommendations

17. About Us & Disclaimer